Vita 34 AG
XETRA:V3V
Vita 34 AG
XETRA:V3V
Price:
4.72 EUR
Market Closed
Updated:
Jun 1, 2024
Vita 34 AG
Total Receivables
|
Vita 34 AG
Total Receivables Peer Comparison
Comparables:
F
FME
FRE
E
1846
SYAB
Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Vita 34 AG
XETRA:V3V
|
Total Receivables
€18.4m
|
CAGR 3-Years
68%
|
CAGR 5-Years
36%
|
CAGR 10-Years
14%
|
|
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
Total Receivables
€4.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
6%
|
|
|
Fresenius SE & Co KGaA
XETRA:FRE
|
Total Receivables
€4B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
1%
|
|
E
|
Euroeyes International Eye Clinic Ltd
HKEX:1846
|
Total Receivables
HK$25.9m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Synlab AG
XETRA:SYAB
|
Total Receivables
€397.6m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Vita 34 AG's Total Receivables?
Total Receivables
18.4m
EUR
18.4m
EUR
Based on the financial report for Dec 31, 2023, Vita 34 AG's Total Receivables amounts to 18.4m EUR.
What is Vita 34 AG's Total Receivables growth rate?
Total Receivables CAGR 10Y
14%
14%
Over the last year, the Total Receivables growth was -4%. The average annual Total Receivables growth rates for Vita 34 AG have been 68% over the past three years , 36% over the past five years , and 14% over the past ten years .
You don't have any saved screeners yet
